AA
Ascentage Pharma Group International
AAPG · NASDAQ
$16.00 +0.44% (+$0.07)
1M -11.54%
Market Cap ¥2.55B
P/E Ratio -
Div. Yield -
ROE 171.96%
Piotroski F-Score Weak
2/9Valuation
64 /100
Fair P/B 1.93x
P/S 4.57x
EV/EBITDA N/A
Growth
100 /100
Growing Book val. growth 48.02%
Rev. growth 38.61%
FCF growth N/A
Profitability
20 /100
Weak Net margin 216.47%
Op. margin 211.14%
FCF margin 215.17%
Quality
2 /100
Poor ROE 171.96%
ROA 30.48%
Asset turnover 0.14x
Debt
37 /100
Moderate Current ratio 1.79x
Int. coverage -22.42x
Debt/Equity 1.49x
Stability
26 /100
Unstable Rev. volatility 209.49%
EPS volatility 122.93%
Profitable years 0
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre AAPG
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Dajun Yang
Employees
767
Headquarters
Suzhou
Evenimente viitoare
31 MAR.
Earnings
Upcoming earnings report